Levomilnacipran

Fetzim

BrazilAuthorisedAuthorised 13 May 2019

Ask Osler about it

In other countries

The same active substances on other registers, the same brand first.

FetzimaCanada · 40 MG · Capsule (Extended-Release) · Abbvie CorporationSame substance
FetzimaCanada · 80 MG · Capsule (Extended-Release) · Abbvie CorporationSame substance
FetzimaCanada · 120 MG · Capsule (Extended-Release) · Abbvie CorporationSame substance
FetzimaUnited States · 120MG BASE, 20MG BASE, 40MG BASE … · capsule, extended release · AbbvieSame substance
Levomilnacipran HydrochlorideUnited States · 120MG BASE, 20MG BASE, 40MG BASE … · capsule, extended release · HikmaSame substance
LevomilnacipranUnited States · 120MG, 20MG, 40MG … · capsule, extended release · Zydus Pharms USA INCSame substance

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Levomilnacipran

Fetzim

BrazilAuthorisedAuthorised 13 May 2019

Ask Osler about it

In other countries

The same active substances on other registers, the same brand first.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Anvisa, Brazil

Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.

Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Levomilnacipran
Register: Brazil (Anvisa)
Status: Authorised
Status in the register: Ativo
Authorised: 13 May 2019
Registration: 101470187
Marketing authorisation holder: Allergan Produtos Farmacêuticos Ltda
ATC code: N06A
Group: Nervous system
Procedure: Registered